Vanway

Vanway is a biotechnology company specializing in the engineering of next-generation Adeno-associated virus (AAV) vectors for gene therapy applications. The company utilizes a proprietary high-throughput screening and directed evolution platform to develop AAV capsids with improved tissue specificity, reduced immunogenicity, and enhanced manufacturing yields. Headquartered in Beijing, Vanway focuses on addressing the delivery limitations of current genetic medicines in therapeutic areas such as the central nervous system, muscle, and liver. Their technology integrates synthetic biology with advanced bioinformatics to create a library of optimized viral variants. By improving the precision of gene delivery, Vanway aims to enable safer and more effective treatments for a wide range of rare and complex genetic disorders.